Westlake Village BioPartners

Westlake Village BioPartners

Westlake Village BioPartners invests in life sciences companies.

Westlake Village BioPartners is a venture capital firm based in Westlake Village, California. The firm seeks to invest in biotechnology, life-science, healthcare, and technology sectors.

Westlake Village BioPartners is a venture capital firm focused on incubating and building life sciences companies with entrepreneurs that have the potential to bring therapies and technologies to patients. The Westlake model is built on the founding team's experience in successfully identifying and developing breakthrough therapies and building organizations.

Investment

Westlake Village BioPartners' investments include Tmunity Therapeutics and ArsenalBio.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Tmunity Therapeutics

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

3 Results
Results per page:
Page 1 of 1

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Westlake BioPartners Fund I, L.P.
320,000,000
320,000,000
September 4, 2018
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Agnes So

Vice President Finance

Beth Seidenberg, MD

Founding Managing Director

Desmond Padhi, B.Sc., Pharm. D.

Associate Partner

Kelli McKeirnan

Senior Executive Assistant

Scott Ryles

Chief Operating Officer

Sean Harper, MD

Founding Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Westlake Village BioPartners
February 17, 2021
www.prnewswire.com:443
/PRNewswire/ -- Westlake Village BioPartners today announced the appointment of Peter Calveley to the position of Chief Operating Officer. Mr. Calveley will be...
Neuron23
December 16, 2020
www.prnewswire.com:443
/PRNewswire/ -- Neuron23TM Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and...
Crunchbase News
December 15, 2020
Crunchbase News
Crunchbase News' top picks of the news to stay current in the VC and startup world.
Amirah Al Idrus
December 15, 2020
FierceBiotech
Since unveiling Westlake Village BioPartners with a $320 million fund, Beth Seidenberg and Sean Harper have invested in or incubated 11 companies Now, Westlake has raised another $500 million for biotech bets, of which $430 million will back the series A rounds of about 12 startups and support later rounds for the most promising of the bunch.
Westlake Village BioPartners
December 15, 2020
www.prnewswire.com:443
/PRNewswire/ -- Westlake Village BioPartners today announced the launch of two new funds totaling $500 million to build and invest in promising life sciences...
ACELYRIN
December 15, 2020
www.prnewswire.com:443
/PRNewswire/ -- ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.